ESCAPE-NEXT Trial

ESCAPE-NEXT Trial Logo
ESCAPE-NEXT Trial Portal Login
ESCAPE-NEXT Trial Portal Dashboard

Project Decription

ESCAPE-NEXT is a multicentre, randomized, double-blinded, placebo-controlled, parallel Group, singledose trial designed to determine the efficacy and safety of nerinetide in participants with acute ischemic stroke undergoing endovascular thrombectomy excluding thrombolysis.
 
ESCAPE-NEXT  is a custom designed Electronic Data Capture (EDC), Randomization  and Drug Management (RDM) Interactive Resposive Technology (IRT) developed for the purpose of facilitating the data collection for the ESCAPE-NEXT Trial, while providing the following functions:
  1. Enables randomization of subjects based on a minimal sufficient balance algorithm
  2. Provides the ability to record and store patient profiles
  3. Provides drug management capabilities across multiple sites/locations
  4. Provides functionality for validating the randomization of subjects
  5. Provides an API integration with the IBM EDC solution
  6. Provides a finance module for generating invoices based on patient enrollment and follow-up visits during the trial
  7. Dashboards, charts and reports
  8. Secure & Scalable
 

Other Links: